Tg(tetO-Vpr)L4Kopp
Transgene Detail
|
|
| Symbol: |
Tg(tetO-Vpr)L4Kopp |
| Name: |
transgene insertion L4, Jeffrey Kopp |
| MGI ID: |
MGI:6272817 |
| Synonyms: |
tet-op/Vpr |
| Transgene: |
Tg(tetO-Vpr)L4Kopp Location: unknown
|
| Alliance: |
Tg(tetO-Vpr)L4Kopp page
|
|
|
|
| Transgene Type: |
|
Transgenic (Inducible) |
| Inducer: |
|
doxycycline/tetracycline |
| Mutation: |
|
Insertion
|
| |
|
Mutation details: The Vpr gene derived from the HIV-1 proviral clone pNL43 was inserted 3 to a tetracycline response operon promoter element (tet-op), with transcription initiation from the cytomegalovirus (CMV) promoter. Three transgenic lines were established, L2, L3, and L4.
(J:116927)
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
|
| Original: |
J:116927 Balasubramanyam A, et al., Effects of transgenic expression of HIV-1 Vpr on lipid and energy metabolism in mice. Am J Physiol Endocrinol Metab. 2007 Jan;292(1):E40-8 |
| All: |
2 reference(s) |
|
Analysis Tools
